Größere Probe – besseres Resultat: Liefert Kryobiopsie bessere Ergebnisse als Zangenbiopsie bei vermuteter Pleurakarzinose?

Introduction: Pleuroscopy has significantly improved the diagnostic yield for pleural diseases, including lung cancer with pleural dissemination. However, obtaining suitable samples for genetic analysis in non-small cell lung cancer (NSCLC) remains challenging. Cryobiopsy enables the collection of larger specimens during pleuroscopy. This retrospective study evaluated the impact of incorporating cryobiopsy with forceps biopsy during pleuroscopy on specimen suitability and the success rate of genetic analysis. Methods: This study included 37 patients with suspected malignant pleural effusion who underwent pleuroscopy with both cryobiopsy and forceps biopsy under local anesthesia at our institution between January 2020 and May 2024. The Oncomine Dx Target Test, a next-generation sequencing assay, was performed on all suitable specimens. Pleuroscopic findings included pleural thickening, granular lesions, small nodules, large nodules, and masses larger than 30 mm. Final pathological diagnoses included 23 cases of NSCLC, 5 cases of small cell lung cancer, 7 cases of malignant pleural mesothelioma, 1 case of diffuse large B-cell lymphoma, and 1 case of metastatic pancreatic cancer. Results: The overall diagnostic yield of pleuroscopy was 97.3%. Cryobiopsy achieved a diagnostic yield of 97.3%, while forceps biopsy achieved 89.2 percent, with no statistically significant difference. The diagnostic yield plateaued after the fourth forceps biopsy and after the second cryobiopsy. In patients with NSCLC, specimens obtained by cryobiopsy were significantly more likely to be suitable for genetic analysis (49.1%) than those obtained by forceps biopsy (24.7%; p = 0.004). The combined suitability for genetic analysis of both forceps and cryobiopsy specimens was 69.6%, with a 100% success rate in performing the analysis. Larger pleural tumor size was significantly associated with higher specimen suitability (81.3% vs. 28.6%; p = 0.026). No complications requiring therapeutic intervention were observed.

Authors

Institutions

Publication Details

Journal
Kompass Pneumologie
Published
2026-02-13
DOI
https://doi.org/10.1159/000549480
Primary Topic
Pleural and Pulmonary Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Größere Probe – besseres Resultat: Liefert Kryobiopsie bessere Ergebnisse als Zangenbiopsie bei vermuteter Pleurakarzinose?

Stefanie Keymel
Kompass Pneumologie
Pleural and Pulmonary Diseases
article

Größere Probe – besseres Resultat: Liefert Kryobiopsie bessere Ergebnisse als Zangenbiopsie bei vermuteter Pleurakarzinose?

Stefanie Keymel
article en

Abstract

Introduction: Pleuroscopy has significantly improved the diagnostic yield for pleural diseases, including lung cancer with pleural dissemination. However, obtaining suitable samples for genetic analysis in non-small cell lung cancer (NSCLC) remains challenging. Cryobiopsy enables the collection of larger specimens during pleuroscopy. This retrospective study evaluated the impact of incorporating cryobiopsy with forceps biopsy during pleuroscopy on specimen suitability and the success rate of genetic analysis. Methods: This study included 37 patients with suspected malignant pleural effusion who underwent pleuroscopy with both cryobiopsy and forceps biopsy under local anesthesia at our institution between January 2020 and May 2024. The Oncomine Dx Target Test, a next-generation sequencing assay, was performed on all suitable specimens. Pleuroscopic findings included pleural thickening, granular lesions, small nodules, large nodules, and masses larger than 30 mm. Final pathological diagnoses included 23 cases of NSCLC, 5 cases of small cell lung cancer, 7 cases of malignant pleural mesothelioma, 1 case of diffuse large B-cell lymphoma, and 1 case of metastatic pancreatic cancer. Results: The overall diagnostic yield of pleuroscopy was 97.3%. Cryobiopsy achieved a diagnostic yield of 97.3%, while forceps biopsy achieved 89.2 percent, with no statistically significant difference. The diagnostic yield plateaued after the fourth forceps biopsy and after the second cryobiopsy. In patients with NSCLC, specimens obtained by cryobiopsy were significantly more likely to be suitable for genetic analysis (49.1%) than those obtained by forceps biopsy (24.7%; p = 0.004). The combined suitability for genetic analysis of both forceps and cryobiopsy specimens was 69.6%, with a 100% success rate in performing the analysis. Larger pleural tumor size was significantly associated with higher specimen suitability (81.3% vs. 28.6%; p = 0.026). No complications requiring therapeutic intervention were observed.

Kompass PneumologieVol. 14(1)
Krankenhaus Bethanien (DE)
Openalex Percentile: Top 53%
Pleural and Pulmonary Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.